Aminophylline therapy for idiopathic apnea in premature infants

Effects on lung function

T. Gerhardt, J. McCarthy, Eduardo Bancalari

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

The effect of aminophylline on lung function was studied in 14 premature infants with apnea (gestational age, 30.2 wk; birth weight, 1,052 gm). The infants showed compromised pulmonary function with a large difference in alveolar-arterial PO2 gradient (83.9 mm Hg), a low normal lung compliance of 1.1 ml/cm H2O·kg, and a normal inspiratory resistance of 45.3 cm H20/liter/sec. Aminophylline therapy did not change these functions significantly, but it decreased the incidence of apneic episodes from 29.7 to 4.4 per day. The effectiveness of aminophylline in treating apnea in premature infants must be related to its central stimulating effect and not to an improvement in lung function and oxygenation.

Original languageEnglish
Pages (from-to)801-804
Number of pages4
JournalPediatrics
Volume62
Issue number5
StatePublished - Dec 1 1978

Fingerprint

Aminophylline
Apnea
Premature Infants
Lung
Lung Compliance
Birth Weight
Gestational Age
Therapeutics
Incidence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Aminophylline therapy for idiopathic apnea in premature infants : Effects on lung function. / Gerhardt, T.; McCarthy, J.; Bancalari, Eduardo.

In: Pediatrics, Vol. 62, No. 5, 01.12.1978, p. 801-804.

Research output: Contribution to journalArticle

@article{d0bc5f0c35bd41a58550fcd02c9284a5,
title = "Aminophylline therapy for idiopathic apnea in premature infants: Effects on lung function",
abstract = "The effect of aminophylline on lung function was studied in 14 premature infants with apnea (gestational age, 30.2 wk; birth weight, 1,052 gm). The infants showed compromised pulmonary function with a large difference in alveolar-arterial PO2 gradient (83.9 mm Hg), a low normal lung compliance of 1.1 ml/cm H2O·kg, and a normal inspiratory resistance of 45.3 cm H20/liter/sec. Aminophylline therapy did not change these functions significantly, but it decreased the incidence of apneic episodes from 29.7 to 4.4 per day. The effectiveness of aminophylline in treating apnea in premature infants must be related to its central stimulating effect and not to an improvement in lung function and oxygenation.",
author = "T. Gerhardt and J. McCarthy and Eduardo Bancalari",
year = "1978",
month = "12",
day = "1",
language = "English",
volume = "62",
pages = "801--804",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - Aminophylline therapy for idiopathic apnea in premature infants

T2 - Effects on lung function

AU - Gerhardt, T.

AU - McCarthy, J.

AU - Bancalari, Eduardo

PY - 1978/12/1

Y1 - 1978/12/1

N2 - The effect of aminophylline on lung function was studied in 14 premature infants with apnea (gestational age, 30.2 wk; birth weight, 1,052 gm). The infants showed compromised pulmonary function with a large difference in alveolar-arterial PO2 gradient (83.9 mm Hg), a low normal lung compliance of 1.1 ml/cm H2O·kg, and a normal inspiratory resistance of 45.3 cm H20/liter/sec. Aminophylline therapy did not change these functions significantly, but it decreased the incidence of apneic episodes from 29.7 to 4.4 per day. The effectiveness of aminophylline in treating apnea in premature infants must be related to its central stimulating effect and not to an improvement in lung function and oxygenation.

AB - The effect of aminophylline on lung function was studied in 14 premature infants with apnea (gestational age, 30.2 wk; birth weight, 1,052 gm). The infants showed compromised pulmonary function with a large difference in alveolar-arterial PO2 gradient (83.9 mm Hg), a low normal lung compliance of 1.1 ml/cm H2O·kg, and a normal inspiratory resistance of 45.3 cm H20/liter/sec. Aminophylline therapy did not change these functions significantly, but it decreased the incidence of apneic episodes from 29.7 to 4.4 per day. The effectiveness of aminophylline in treating apnea in premature infants must be related to its central stimulating effect and not to an improvement in lung function and oxygenation.

UR - http://www.scopus.com/inward/record.url?scp=0018087867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018087867&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 801

EP - 804

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -